Euractiv.com

Jian G was found guilty of acting as an agent for a Chinese intelligence service while working for Maximilian Krah, a member of the far-right Alternative for Germany

In today's edition: Chip's Act 2.0 chatter, digitalisation principles

Von der Leyen did not specify where the money was coming from

In today's edition: Pharma package, NGOs, and German long-term care insurance

As part of its efforts to increase European competitiveness, the European Commission adopted a simplification package, the Omnibus I, in February 2025. This covers several areas, such as sustainable finance rules, due diligence reporting and the carbon border adjustment mechanism, among others.

In today's edition: EU-Morocco, soils, food prices

In today's edition: Palm oil, switchgear, omnibus fights

The new investment roadmap will double climate adaptation funding, while targeting lower energy prices and slashing red tape

In today’s edition: European leaders back Donald Trump’s peace plan for Gaza as Hamas remains silent, the EPP stays quiet on whether MEP Dolors Montserrat draws a second salary, and an EU loan proposal and accession gambit expose Brussels’ limits in Ukraine

Speaking at the Warsaw Security Forum, Zelenskyy called for a joint air defence system to counter Russian threats, while Poland’s Tusk warned Europe must stop relying on the US and confront the war as its own

The ECB and key capitals are deeply sceptical about an audacious Commission scheme to hijack Russian assets to bankroll Ukraine

“The number one issue for our members is the Chinese economy itself," according to the EU Chamber of Commerce in China

The two leaders warned that Israel would "finish the job" against Hamas if the Palestinian militant group rejects the deal.

Ireland's 'unsustainable' healthcare budget faces tariff ripple effect and rising drug prices

Senior French foreign ministry officials "did their level best to clip my wings", he said

Even though Moldova’s vote is a bold step towards the bloc, there is still a lot of ground to cover

Animal testing science has developed significantly in 20 years; now it’s time to align industry with new non-animal testing methods

Key disputes centre on approval timelines and environmental risk assessments in the EU’s pharmaceutical reform

With this move, the European Commission would gain great power in monitoring national governments’ progress in rearming

Any other concessions "would undermine our environmental ambitions without putting a stop to the relocation of production to third countries," French Industry Minister Marc Ferracci warned